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Abstract
Hair growth is a highly regulated cyclical process. Immunosuppressive immunophilin ligands such as cyclosporin A (CsA)
and FK506 are known as potent hair growth modulatory agents in rodents and humans that induce active hair growth and
inhibit hair follicle regression. The immunosuppressive effectiveness of these drugs has been generally attributed to
inhibition of T cell activation through well-characterized pathways. Specifically, CsA and FK506 bind to intracellular proteins,
principally cyclophilin A and FKBP12, respectively, and thereby inhibit the phosphatase calcineurin (Cn). The calcineurin
(Cn)/NFAT pathway has an important, but poorly understood, role in the regulation of hair follicle development. Here we
show that a novel-splicing variant of calcineurin Aß CnAß-FK, which is encoded by an intron-retaining mRNA and is deficient
in the autoinhibitory domain, is predominantly expressed in mature follicular keratinocytes but not in the proliferating
keratinocytes of rodents. CnAß-FK was weakly sensitive to Ca
2+ and dephosphorylated NFATc2 under low Ca
2+ levels in
keratinocytes. Inhibition of Cn/NFAT induced hair growth in nude mice. Cyclin G2 was identified as a novel target of the Cn/
NFATc2 pathway and its expression in follicular keratinocytes was reduced by inhibition of Cn/NFAT. Overexpression of
cyclin G2 arrested the cell cycle in follicular keratinocytes in vitro and the Cn inhibitor, cyclosporin A, inhibited nuclear
localization of NFATc2, resulting in decreased cyclin G2 expression in follicular keratinocytes of rats in vivo. We therefore
suggest that the calcineurin/NFAT pathway has a unique regulatory role in hair follicle development.
Citation: Fujimura A, Michiue H, Nishiki T-i, Ohmori I, Wei F-Y, et al. (2011) Expression of a Constitutively Active Calcineurin Encoded by an Intron-Retaining mRNA
in Follicular Keratinocytes. PLoS ONE 6(3): e17685. doi:10.1371/journal.pone.0017685
Editor: Colin Combs, University of North Dakota, United States of America
Received October 27, 2010; Accepted February 7, 2011; Published March 14, 2011
Copyright:  2011 Fujimura et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan and
by a Grant-in-aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tomikt@kumamoto-u.ac.jp
Introduction
The hair follicle is a highly developed organ and the
mechanisms that regulate the hair cycle have been extensively
investigated [1,2]. Immunosuppressant drugs such as cyclosporin
A (CsA) and FK506, which are indispensable for transplantation,
cause hypertrichosis [1,3]; recent studies have shown that this
phenomenon is associated with inhibition of the calcineurin (Cn)/
nuclear factor of activated T cells (NFAT) signaling pathway in
follicular keratinocytes and follicular stem cells [4,5].
Cn, a Ca
2+/calmodulin-dependent serine/threonine phospha-
tase, plays important roles in cooperation with NFAT in various
tissues such as the immune system, cardiac muscle and neurons [6–
8]. After activation via a rise in intracellular Ca
2+ concentration, Cn
dephosphorylates cytoplasmic NFAT (NFATc1-c4); this results in
translocation of NFAT into the nucleus where it binds to DNA to
activate gene transcription [9]. In follicular keratinocytes, NFATc2
regulates the expression of cell cycle-associated proteins, including
p21
waf1/cip1 and p27
kip1, and apoptosis-associated proteins such as
p53, and, consequently, controls the transition from the anagen to
catagen stages [4]. Similarly, in bulge stem cells, NFATc1 regulates
proliferation of follicular stem cells through Cdk4 repression [5].
Cn, which is ubiquitously expressed, is a heterodimer comprised
of a catalytic subunit (CnA) binding with calmodulin (CaM) and a
calcium-binding regulatory B subunit (CnB) [10]. CnA has four
principal domains involved in enzymatic regulation: the N-
terminus catalytic domain, the CnB-binding domain, the CaM-
binding domain, and the C-terminus autoinhibitory domain. The
latter conformationally blocks phosphatase activity and is released
from the catalytic domain in response to Ca
2+/CaM binding [10].
Three isoforms (alpha, beta, gamma) of the CnA subunit have
been identified. The alpha and beta (ß) isoforms are expressed in a
range of tissues whereas the gamma isoform is predominantly
expressed in the testis [11–13]. Although eleven splicing variants of
CnAß have been identified, only four of these variants appear to
have functional phosphatase activity as they contain a conserved
catalytic domain (ID No. GC10M074866 in GeneCards). In-
creased levels of intracellular Ca
2+ are believed to trigger Cn
activation and to be a key regulator of a variety of physiological
and pathological processes [10,14,15]. In general, follicular
keratinocytes are cultured under low Ca
2+ (,50 mM) conditions
and an increase in intracellular/extracellular Ca
2+ concentration
readily induces differentiation [16,17]. Currently, little is known
about Cn activation under such low Ca
2+ conditions in follicular
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the growth of hair follicles. Interestingly, it has been pointed out
that Cn is functionally active and activates NFATc2-dependent
gene transcription in follicular keratinocytes, resulting in inhibition
of the hair cycle [4]. Overall, the molecular mechanism of Cn
activation in follicular keratinocytes seems to differ from that in
other tissues such as neurons and T cells. In the present study, we
show that a novel splicing variant of CnAß(CnAßin follicular
keratinocytes, CnAß-FK) is predominantly expressed in follicular
keratinocytes. CnAß-FK was deficient in the autoinhibitory
domain and was therefore active independently of Ca
2+ levels.
To clarify the roles of CnAß-FK in the hair cycle, we sought to
identify the cell cycle regulators whose expression was regulated by
CnAß-FK/NFATc2. We found that cyclin G2, an atypical cyclin
that correlates with cell cycle arrest, was regulated by CnAß-FK/
NFATc2 [18,19]. Our findings provide the first indication of the
role of functionally active Cn in follicular keratinocytes.
Materials and Methods
Cell Culture
PHK16-0b (PHK) cells established from human keratinocytes,
HEK293 cells and HeLa cells were provided by the Health
Science Research Resources Bank (Osaka, Japan). PHK cells were
cultured in the serum-free medium EpiLife in the presence of
60 mM CaCl2 (Cascade Biologics), supplemented with EDGS
(growth supplement, S-012-5, Cascade Biologics), penicillin,
streptomycin, and amphotericin B (Nacalai tesque, Japan). At
80% confluence, cells were trypsinized (Trypsin/EDTA, Toyobo)
and subcultured onto culture plates coated with human Type-1
collagen (Coating Matrix Kit, Cascade Biologics). HEK 293 cells
and HeLa cells were cultured in D-MEM (Gibco) with fetal bovine
serum (10%) and antibiotics.
Cloning of a Splicing Variant of CnAßCnAß-FK)
A cDNA library was constructed from PHK cells by Takara Bio
(Ohtsu, Japan). Briefly, cDNAs were synthesized from PHK cells
using an Oligo(dT)-Anchor primer (Takara Bio) and subcloned
into the EcoRI/XhoI sites of pBluescript II SK(+) plasmids. The
full nucleotide sequence of CnAß-FK was determined by PCR and
nested-PCR using the primers listed in Tables S1-A and -B. PCR
products were cloned into pCR-Blunt II-TOPO (Invitrogen) and
analyzed using the listed sequencing primers (Table S1-a and -b).
For further determination of the C-terminus, 39-RACE (Rapid
Amplification of cDNA Ends) was performed with the 39 Full
RACE Core Set (Takara Bio) (Table S1-c). mRNAs were isolated
from PHK cells using the FastTrack 2.0 kit (Invitrogen) according
to manufacturer’s protocol. Details of the primer sequences and
cloning process are given in Table S1. PCR was performed using
the KOD FX DNA polymerase (Toyobo).
Calcineurin Phosphatase Assay
Calcineurin activity was determined by a calcineurin phospha-
tase assay that measures dephosphorylation of p-nitrophenol
phosphate (pNPP). HEK293 cells were transfected with
pcDNA3.1 plasmid (Invitrogen) containing human CnAß-FK
cDNA. After 24 h, the cells were harvested and lysed in a buffer
comprised of 20 mM Tris-HCl (pH 7.2), 1 mM EGTA, 100 mM
sodium chloride, 1% Triton X-100, and Protease Inhibitor
Cocktail (Roche). Mouse brain and PHK cells were lysed in the
same buffer. After centrifugation at 65,000 g, each supernatant
(1 mg of total protein) was immunoprecipitated using 10 mgo f
polyclonal anti-CnAß antibodies (Chemicon). Immunoprecipitat-
ed samples were incubated on 96-well microplates in a Cn assay
buffer (50 mM Tris-HCl (pH 7.2), 1 mg/ml CaM, 1% BSA.
1 mM okadaic acid) in the presence or absence of 2 mM CaCl2,
2 mM EGTA or 1 mM CsA at 37uC for 15 min. After adding
1 mg/ml pNPP, the samples were further incubated for 15 min.
The reaction was stopped by adding sodium hydroxide (final
concentration, 300 mM), then the absorbance at 405 nm was
measured with a microplate reader. Purified bovine CaN was
purchased from Upstate (14-390). In each sample, the data were
standardized against Ca
2+ stimulation data.
Animal Studies
The effect of 11R-VIVIT on hair growth in vivo was investigated
in male nude mice aged 28 days (BALB/c Slc-nu, Shimizu
Laboratory Supplies, Kyoto). For drug application, 11R-VIVIT
(10 mg) was dissolved in 1 g hydrophilic ointment (Merck).
Twenty-five mg of the ointment containing 250 mg of 11R-VIVIT
was applied to the skins of the mice once per day. After application
of the ointment for seven days, the animals were killed, and the
skins excised and immediately fixed with 4% paraformaldehyde
(PFA) at 4uC overnight. As a control, mice were treated as above,
but with ointment lacking 11R-VIVIT.
To investigate the effect of CsA, Wistar rats aged 24 days
(Shimizu Laboratory Supplies) were intraperitoneally injected with
100 mg/kg CsA on 3 successive days. The animals were then
killed and the skins then excised and used for immunohistochem-
istry. As a control, rats were injected with vehicle only. All
procedures were approved by the Ethics Review Committee for
Animal Experimentation of our institute (OKU-2009192).
In Situ Hybridization
In situ hybridization was carried out as described previously
[20]. Briefly, probes for detecting rat CnAß-FK mRNA were
prepared by first cloning the full sequence of intron 11 of CnAß-
FK cDNA (Figure 2A) into pCR-Blunt II-TOPO (Invitrogen). The
plasmid was linearized and transcribed with SP6 or T7 RNA
polymerase. Digoxigenin-UTP-labeled RNA probes were gener-
ated from the DNA template using a DIG RNA labeling kit
(Roche). Fresh frozen sections (6 mm thickness) were prepared on
silane-coated glass microscope slides and immediately fixed with
4% paraformaldehyde (PFA) and 0.1% glutaraldehyde (GA) in
0.1 M phosphate buffer (PB, pH 7.4) for 15 min. Prior to
hybridization, RNA probes were denatured at 80uC for 5 min.
Hybridization was performed at 60uC for 16 h with a digoxigenin-
labeled probe (1 mg/ml) in hybridization buffer (50% formamide,
26SSC, 1% SDS). After a series of wash steps, the single-stranded
RNA probes were removed with RNase A (10 mg/ml) at 37uC for
30 min. The sections were incubated with alkaline phosphatase-
conjugated anti-DIG antibody and hybridization signals were
detected by an NBT/BCIP colorimetric reaction according to
manufacturer’s recommendation (Roche). For specificity control, a
sense probe was used.
Immunofluorescent Staining
Skin sections from male Wistar rats were immunofluorescently
stained as follows. Excised skin samples were immediately frozen
in Optimal Cutting Temperature compound (Sakura Finetek,
Japan) and sequentially sectioned at a thickness of 10 mm. The
sections were fixed with 4% PFA in 0.1 M phosphate buffer
(pH 7.4) for 15 min and then incubated with 5% normal goat
serum (Abcam) in blocking buffer (16PBS, 0.3% Triton X-100) at
room temperature for 1 h. After washing in PBS, the sections were
incubated with primary antibodies in dilution buffer (16 PBS,
10% BSA, 0.3% Triton X-100) at 4uC overnight. The sections
were incubated with secondary antibodies in dilution buffer at
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washed, stained with Hoechst 33258 (1 mg/ml) for 2 min, and
viewed using a confocal microscope (FluoView
TM FV300,
OLYMPUS). The following primary and secondary antibodies
were used: NFATc2 (Upstate, 07-136, rabbit antiserum, 1:100),
NFATc1 (Santa Cruz, 7A6, mouse, 1:100), and cyclin G2 (Abcam,
ab5502, rabbit polyclonal, 1:200). Anti-mouse or anti-rabbit IgG
(Molecular Probes, Alexa Fluor 488- or 555- conjugated goat IgG,
1:200) were used as secondary antibodies.
For immunocytochemistry, PHK cells were cultured on glass-
bottomed dishes coated with human Type-1 collagen and grown
to 80% confluence. After incubation in high [Ca
2+] medium for
4 h, the cells were immediately fixed with 4% PFA in PB,
permeabilized with 0.5% Triton X-100 and blocked with 10%
BSA. The following primary and fluorochrome-conjugated
secondary antibodies were used: NFATc2 (Upstate, 07-136, rabbit
antiserum, 1:250) and anti-rabbit IgG (Molecular Probes, Alexa
Fluor 488-conjugated goat IgG, 1:500).
Western Blotting Analysis
Skins were excised from male Wistar rats at postnatal day 7 and
the epidermal and dermal layers were separated with dispase at
4uC overnight. The isolated samples were frozen in liquid
nitrogen, pulverized and lysed in lysis buffer, followed by boiling
in sample buffer (50 mM Tris-HCl, pH 6.8, 5% glycerol, 1%
SDS, 0.1% BPB, 2% 2-ME). PHK 16-0b cells and HEK293 cells
were harvested at 80% confluence. After sonication, cell lysates
were boiled in sample buffer. The cell and tissue lysates were
separated by SDS-PAGE on a 10% acrylamide gel and transferred
to a nitrocellulose membrane using the iBlot Dry Blotting System
(Invitrogen). After blocking with 5% skim milk in TBST, the blots
were incubated with primary antibodies against the following
proteins: CnA (epitope: the middle (246–265) of the amino acid
sequence, SPA-610, Stressgen Bioreagents Corp.), CnAß (epitope:
the N-terminus (18–28) of the amino acid sequence, AB1697, Lot
No. 0612047223, Chemicon), cyclin G2 (1572-1, Epitomics and
ab5502, Abcam), p21 (sc-756, Santa Cruz), ß-actin (A-5316,
Sigma), and GAPDH (sc-32233, Santa Cruz). These primary
antibodies and HRP-conjugated secondary antibodies (Sigma)
were appropriately diluted according to manufacturer’s recom-
mendation.
Microarray Analysis
Microarray analysis was performed using a human 44K whole
genome oligo DNA chip (Agilent Technologies) as described
previously [21]. Briefly, mRNAs (150 ng) from PHK cells treated
with 1 mM CsA or 3 mM 11R-VIVIT for 24 h were pooled into
one master total RNA mix, and labeled with Cy-3 or Cy-5 using
an Agilent Low RNA Input Fluorescent Linear Amplification Kit
(Agilent). Hybridization and wash processes were performed
according to the manufacturer’s instructions, and hybridized
microarrays were scanned using an Agilent Microarray scanner
G2565BA. For detection of genes with significant differential
expression between the control group and those treated with CsA
or 11R-VIVIT, each slide image was processed using the Agilent
Feature Extraction ver.8.5.1.1. All data is MIAME compliant and
the raw data has been deposited in a MIAME compliant database,
Gene Expression Omnibus (accession number GSE25175).
Proliferation Assay and Vector Constructs
The effect of cyclin G2 expression on keratinocyte proliferation
was analyzed in PHK cells using a WST-1 assay (Roche) as
described previously [22]. Recombinant adenovirus containing
human ccng2 (cyclin G2) cDNA, chicken ß-actin promoter and
SV40 polyadenylation signal was produced using the Adenovirus
Expression Vector Kit (Takara) as described previously [22].
Human ccng2 gene was purchased from ATCC (item number,
9117362; GenBank, BC032518). The LacZ recombinant adeno-
virus was also produced following the manufacturer’s protocol. For
the transient gene expression of CnAß-FK in HeLa cells, the open
reading frame of CnAß-FK cDNA was subcloned into the pcDNA
3.1/V5-His vector (Invitrogen) using a TOPO TA Expression Kit
(Invitrogen) and the cells were transfected with the plasmids using
Lipofectamine 2000 (Invitrogen).
Statistics
Data are shown as means 6 S.E. The data were analyzed either
by Student’s t test to identify significant differences between two
groups or by Scheffe’s posttest analysis following two-way
ANOVA to compare multiple groups. P values less than 0.05
were considered significant.
Results
Molecular Characteristics of a Novel Calcineurin Aß
Isoform
To investigate the expression of calcineurin A (CnA) in hair
follicles (HF), we first examined CnA expression in primary human
keratinocyte (PHK) cells. Western blot analyses using anti-CnA
antibodies, which recognize the alpha and ß isoforms of CnA,
identified two bands in PHK cells: an atypical CnA band
(,48 kDa) and the typical CnA (,60 kDa) band (Fig. 1A). The
atypical CnA band was not observed in other organs including
mouse brain (Fig. 1A), liver, heart, kidney and lung (data not
shown). This band could stably be detected using anti-CnAß
antibodies (Fig. 1A), suggesting that it represents a ß isoform of
CnA. We previously reported that calpain, a Ca
2+-activated
neutral cysteine protease, cleaved CnA alpha and generated a
truncation product with a molecular mass of ,48 kDa in
excessively excited neurons and in Alzheimer’s brain tissue
[15,23]. We therefore postulated that the atypical CnAß was a
truncated product of CnAß produced by calpain. To investigate
this possibility, PHK cells were treated with ALLM, a calpain
inhibitor. However, the expression of the 48 kDa and 60 kDa
CnAb were not changed by this treatment (Fig. 1A). Moreover,
Ca
2+ stimulation did not alter 48 kDa CnA expression and no
additional bands were observed in PHK cells (Fig. 1A). These
results suggested that the atypical CnA was not generated by
calpain. Next, we determined whether the atypical CnAß was
expressed in dermis containing HF and in epidermis without HF
in rat skin. Both the atypical and typical CnAß were observed in
rat dermis whereas only typical CnAß was expressed in rat
epidermis (Fig. 1B). These results suggested that the atypical CnAß
might be expressed in hair follicles but not in the epidermis.
To investigate the molecular characteristics of the atypical
CnAß, we constructed a cDNA library from PHK cells and cloned
a splicing variant of CnAß (CnAß-FK) corresponding to the
48 kDa CnAß. Sequence analysis of the CnAß-FK cDNA revealed
that it was composed of CnAß coding sequence from exons 1–11
(1271 bp), intron 11 (1669 bp), exon 12 (98 bp), and part of intron
12 (930 bp) ending with a poly A tail (Fig. S1). A stop codon was
present at the junction of exon 11 and intron 11 (Figure 1D & S1).
As a result, the intron-retaining mRNA encoded a truncated
CnAß that lacked the autoinhibitory domain (Figure 1C & S2).
It was previously shown that artificial truncated form of CnA,
which also lacked an autoinhibitory domain, had Ca
2+-indepen-
dent Cn activity [15,24]. To investigate whether CnAß-FK
showed Ca
2+-independent activity, we examined Cn activity in
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CnAß-FK was stably expressed in the cells (Fig. 1E). Cn activity of
a brain lysate and of purified Cn was Ca
2+-dependent, whereas
PHK cells had high Cn activity under low Ca
2+ conditions
(Fig. 1F). In cells overexpressing CnAß-FK, moreover, the activity
was weakly sensitive to Ca
2+ (Fig. 1F). CnAß-FK activity was
inhibited by cyclosporin A (CsA), a potent inhibitor of Cn.
The subcellular distribution of NFAT was examined by optical
imaging in PHK and HEK293 cells that had been transfected with
GFP-NFATc2 cDNA. In HEK293 cells lacking CnAß-FK, NFAT
was located in the cytoplasm (Fig. 1G). In intact PHK cells, on the
other hand, NFAT was observed in both the nucleus and
cytoplasm (Fig. 1G). In PHK cells treated with the membrane-
permeable specific NFAT inhibitor, 11R-VIVIT, which inhibits
nuclear translocation of NFAT by blocking the NFAT-Cn
interaction [25,26], NFAT was observed in the cytoplasm but
not in the nucleus (Fig. 1G). In contrast, PHK cells stimulated with
Ca
2+ showed translocation of NFAT to the nucleus (Fig. 1G).
Moreover, the pattern of distribution of endogenous NFATc2 was
observed in PHK cells under a low Ca
2+ (40 mM) concentration.
Endogenous NFATc2 was observed in both the nucleus and
cytoplasm (Fig. S3). Our observations suggest that Cn has high
activity in PHK cells regardless of intracellular Ca
2+ levels and
induces NFAT translocation into the nucleus.
Localization of CnAß–FK mRNA in Rat Skin
Immunohistochemical analysis using CnAß antibodies showed
that CnAß was strongly expressed in both epidermal and follicular
keratinocytes of the rat skin (Fig. S4). CnAßwas also observed in the
cells of the outer root sheath (ORS) and the inner root sheath (IRS)
but was undetectable in other cells (Fig. S4). However, the
immunohistochemical analysis does not distinguish signals from
typical CnAß (,60 kDa) and CnAß-FK. Therefore, we performed
an in situ hybridization (ISH) using a specific anti-sense probe to
CnAß-FK mRNA to verify the distribution of CnAß-FK mRNA in
rat skin (Fig. 2A). During the late phase of the anagen stage (P28), in
which almost follicular keratinocytes are mature, CnAß-FK mRNA
was strongly expressed in follicular keratinocytes of the hair shaft and
matrix (Fig. 2B). It was also strongly expressed in IRS cells but was
not expressed in ORS cells or the dermal papillae of hair follicles
(Fig. 2B and 3D). Strong mRNA expression was also seen in cells of
the sebaceous gland (SG) (Fig. 2D). In contrast, no CnAß-FK mRNA
was detected in either bulge stem cells or epidermal keratinocytes
(Fig. 2D). Interestingly, at an early phase of the anagen stage (P25)
and at the transition from telogen to anagen stages (P24), when
immature follicular keratinocytes in hair germ (HG) are proliferating,
CnAß-FK mRNA was not expressed in the keratinocytes of the HG
(Fig. S5A–D). At these stages, high levels of mRNA expression were
only detected in the SG (Fig. S5A–D). Moreover, at the catagen and
telogen stages, when follicular keratinocytes were absent, CnAß-FK
mRNA expression was restricted to SG cells (Fig. 3B, C, E and F).
CnAß-FK was also expressed in human hair follicle (Fig. S6). These
results agree with those from the western blotting analysis shown in
Fig. 1B, and suggest that CnAß-FK may be predominantly expressed
in mature follicular keratinocytes and SG cells.
If CnAß-FK is constitutively active as shown in Fig. 1, then it is
possible that some NFATc2 might be localized in the nuclei of
mature follicular keratinocytes and SG cells. To investigate this
hypothesis, we determined the subcellular distribution of NFATc2 at
each hair cycle stage in rat skin. At the transition from the catagen to
telogen stages (P49), NFATc2 was present in the nuclei of cells of the
SG (arrowheads in Fig. 3I),whereas it was expressed inthe cytoplasm
but not the nuclei of dermal papilla cells and follicular keratinocytes
(Fig. 3I). Nuclear localization of NFATc2 was also observed in SG
cellsduringthelatephaseoftheanagenstage(arrowheadsinFig.3H).
Moreover, NFATc2 was strongly expressed in the nuclei of mature
follicular keratinocytes at the late phase of the anagen stage (Fig. 3G,
J–L). NFATc1 was specifically expressed in bulge stem cells (Fig. 3H)
as previously reported [5]. At P24 and P25, NFATc2 was observed in
the cytoplasm of proliferating follicular keratinocytes in which CnAß-
FK was not expressed (compareFig. S5A and C with Fig. S5E and F).
These results suggestthat CnAß-FK localized in maturekeratinocytes
and SG cells, and that a consequence of this localization was the
translocation of NFATc2 in the cell nuclei.
Effect of NFAT Inhibition on Hair Growth in Nude Mice
Cyclosporin A (CsA) and FK506 are widely used immunosup-
pressants; both have the well-known side effect of causing
hypertrichosis [1]. The Cn/NFAT pathway is involved in the
mechanism of this side effect [1,3]. We gave a topical application of
an ointment containing 11R-VIVIT to the vertex of nude mice on
seven successive days from postnatal day 28 (late phase of the
anagen stage). Significant hair growth was observed in the area
treated with ointment containing 11R-VIVIT (Figure 4B). Histo-
logical analysis of skin specimens from control nude mice revealed
dystrophic follicles containing fragmented hair shafts that did not
emerge from the hair follicles, and showed little birefringence of the
cuticle (Fig. 4C). In contrast, treatment with 11R-VIVIT resulted in
relatively normal follicles containing well-differentiated straight hair
shafts that emergedfrom hair follicles and reached the surface of the
skin, and showed clear birefringence of the cuticle (Fig. 4C).
Moreover, the number of hair follicles containing birefringent hair
was significantly increased in 11R-VIVIT-treated mice compared
to the control mice (Fig. 4D). These results suggest that inhibition of
CN/NFAT signaling pathway enhanced hair growth.
Involvement of Cyclin G2 in Cell Cycle Arrest in Follicular
Keratinocytes
Asshownin Figure1G,NFATc2isa target ofCnAß-FK.NFATc2
has been shown to regulate the hair cycle by determining the level of
Figure 1. Molecular characteristics of a novel variant of CnAß (CnAß-FK). (A) CnA expression in PHK cells and mouse brain. PHK cells were
treated with 1 mM ALLM or incubated with 1 mM Ca
2+ for 24 h. (B) Expression of CnAß in the dermis and epidermis of rat. An atypical CnAß with a
molecular mass of 48 kDa was observed in the dermis and PHK cells. ß -actin expression (Actin) was used as the control. (C) Comparison of the
primary structure of CnAß-FK with other splicing variants of CnAß. CnAß-FK lacks an autoinhibitory domain. The gray box in variant 2 represents
amino acid sequences translated from mRNAs of the intron. (D) Comparison of the nucleotide sequence of the 39 terminus of CnAß-FK cDNA with
that of variant 1. Blue box, cDNA derived from exons; red box, cDNA derived from introns. *, stop codon. (E) Ectopic expression of CnAß-FK in HEK293
cells. PHK cells lysate was loaded as a positive control. (F) Relative CnAß activity in brain lysate and each cell line. HEK 293 cells were transfected with
pcDNA3.1 plasmid containing CnAß-FK cDNA and harvested 24 h later. Cn phosphatase activity was assayed in the presence or absence of 1 mM
Ca
2+ or 1 mM cyclosporin A (CsA). Phosphatase activity of each sample was standardized with that in the presence of Ca
2+ but not CsA. Purified CnA
from bovine brain was used as a positive control. n=5 each sample. *P,0.01. (G) Subcellular distribution of NFATc2 in PHK cells and HEK293 cells.
Cells were transfected with a GFP-NFATc2 plasmid and incubated for 24 h. PHK cells were then treated with 11R-VIVIT (1 mM) for 6 h or stimulated
with Ca
2+ (1 mM) for 15 min. Note that GFP signals were seen not only in the cytoplasm but also in the nucleus of control PHK cells. In HEK293 cells,
under basal conditions, GFP signals were seen only in the cytoplasm. Scale bar, 10 mm.
doi:10.1371/journal.pone.0017685.g001
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proteins [4]. To investigate the mechanism of regulation of the hair
cycle after activation of CnAß-FK/NFATc2, we carried out a DNA
microarray analysis to identify genes down-regulated by 11R-VIVIT
and CsA in PHK cells. Twenty-four genes showed repressed
expression after 11R-VIVIT and CsA treatments (Fig. 5A). Of these
genes, the largest effect was shown by ccng2 (Fig. 5A), which encodes
the unconventional cyclin G2. Cyclin G2 is an atypical cyclin that
associates with protein phosphatase 2A but not proteins of the cell
cycle-associated Cdk family; it is involved in cell cycle arrest and
apoptosis [18,19,27]. The effect of 11R-VIVIT on time-dependent
changes in cyclin G2 expression was examined in PHK cells. Cyclin
G2 expression decreased with time following 11R-VIVIT application
in a similar fashion to that of p21
waf/cip1, which has been identified as
a target protein of Cn/NFAT in the hair follicle (Fig. 5B and C). We
further examined whether overexpression of CnAß-FK induced
endogenous cyclin G2 in Hela cells. Exogenous CnAß-FK induced
the cyclin G2expression (Fig. S7). Moreover, overexpression of cyclin
G2 inhibited the proliferation of PHK cells compared to control and
LacZ-overexpressing cells (Figure 5D).
Cyclin G2 was strongly expressed in the mature keratinocytes
localized distally in the hair shaft (arrowheads), whereas the
Figure 2. Localization of CnAß -FK mRNA in rat skin. (A) Schema of sense and anti-sense probes used for in situ hybridization (ISH). The probes
correspond to the full sequence of intron 11 and are specific for CnAß-FK mRNA. Sense probes were used as the negative control. (B and C)
Expression of CnAß-FK mRNA in rat skin. Skin sections from the parietal region were prepared from male Wistar rat (postnatal day 28, corresponding
to the late phase of the second anagen). (D) Higher magnification micrograph to show the mRNA expression in epidermais and SG. Epi, epidermis; SG,
sebaceous gland. Scale bars in B and C, 1 mm; in D, 50 mm.
doi:10.1371/journal.pone.0017685.g002
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proximal part of the hair shaft (arrows) at the first anagen stage
(Fig. 5E). In HF at the telogen stage, cyclin G2 expression was
weak in the hair germ region and was undetectable in bulge stem
cells and in DP cells. In contrast, cyclin G2 was detected in SG
cells where CnAß-FK mRNA was detected at the telogen stage
Figure 3. CnAß-FK mRNA and NFATc2 Localizations in rat skin. (A) Time-scale of the hair cycle in male Wister rats. Each phase was determined
usingcriteriadescribedpreviously[42].Theintensity ofthegray shadingindicatestherate ofproliferation offollicularkeratinocytes:white,proliferation
activity,black. (B–F) Distribution of CnAß-FK mRNA. B and C, telogen stage. D, late phase of anagen stage. E and F, transition stage from catagen to
telogen. (C and F) Sections were counter-stained using hematoxylin (blue staining). (G–J) Results of immunohistochemical analysis of NFATc2 (green)
andNFATc1 (red)in hair follicles.Cell nucleiwere visualized byHoechst staining (bluein G–I andK).(G)NFATc2 expression in hair follicle atpostnatal day
28. (H) NFATc2 and NFATc1 expression in bulge and SG cells at postnatal day 28. Arrows, NFATc1 expression in bulge cells. Arrowheads, nuclear
localization of NFATc2 in SG cells. (I) NFATc2 expression at postnatal day 49. Arrowheads indicate localization of NFATc2 in nuclei of SG cells. (J and K)
Higher magnification image of the boxed region in G. (J) NFATc2 expression. (K) Hoechst staining. (L) Hematoxylin-eosin (H.E.) staining of hair follicles at
postnatal day 28. After immunofluorescence staining, H.E. staining was performed in the same section to reveal the histology of hair follicle. DP, dermal
papillae; IRS, inner root sheath; ORS, outer root sheath; SG, sebaceous gland. Scale bars in B–F, 100 mm; in B, C, and G–K, 50 mm.
doi:10.1371/journal.pone.0017685.g003
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treated with CsA for three successive days from postnatal day 24
(anagen stage) for the subcellular localization of NFATc2 and
cyclin G2 expression (Fig. S8). In vehicle-treated rats, NFATc2
was observed in both nuclei (arrows in Fig. S8C) and cytoplasm of
follicular keratinocytes in the HF. Cyclin G2 expression was also
detected in many of the follicular keratinocytes in the HF of
control rats (Fig. S8E). In contrast, NFATc2 was mainly detected
in the cytoplasm of follicular keratinocytes of CsA-treated rats (Fig.
S8F and G). A low level of cyclin G2 expression was observed in
the follicular keratinocytes of CsA-treated rats (Fig. S8I).
Discussion
The physiological functions of the CN/NFAT signaling
pathway have been investigated in diverse organs including the
immune system, the neuronal system and the hair follicle. In the
hair follicle, the pathway is functionally active and its inhibition
enhances hair growth [4,5]. A recent study elucidated many details
of the molecular mechanism of this pathway in hair stem cells [5].
It was found that NFATc1 was specifically expressed and that the
Cn/NFATc1 pathway down-regulated proliferation of hair stem
cells [5]. However, the precise molecular mechanisms involved in
Figure 4. Effects of 11R-VIVIT on hair growth induction in nude mice. (A) The vertex region (blue circle) was chosen as the treatment spot
with 11R-VIVIT. (B) Macroscopic and microscopic assessment of hair growth induction. Upper panels, control mouse treated with ointment only.
Lower panels, 11R-VIVIT-treated mouse. Right panels, longitudinal sections stained with H. E. Scale bar, 1 mm. (C) Histological features of the skin of
control and 11R-VIVIT-treated mice. i–iv, control mice; v–viii, 11R-VIVIT-treated mice. Longitudinal (i, ii, v and vi) and transverse (iii, iv, vii and viii)
sections stained with H.E. (i, iii, v and vii), and the same sections assessed for birefringent hair shafts using a polarizing microscope (ii, iv, vi and viii).
Scale bars in ii and v, 500 mm; in iv and vii, 200 mm. (D) Hair growth in control (2) and 11R-VIVIT-treated (+) mice was quantified using a polarizing
microscope by counting the number of hair follicles containing birefringent hair shafts. n=10 each. *P,0.0005.
doi:10.1371/journal.pone.0017685.g004
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17685Figure 5. Cyclin G2 is a target molecule of Cn/NFATc2 in follicular keratinocytes. (A) The microarray analysis identified 24 genes that
showed down-regulated expression in PHK cells treated with either 11R-VIVIT or CsA; ccng2 (cyclin G2) expression showed the greatest decrease after
Cn/NFAT inhibition. (B) Time-dependent changes in cyclin G2 and p21
waf/cip1 expression in PHK cells treated with 11R-VIVIT. (C) Quantitative analysis
of the changes in expression changes of cyclin G2 and p21
waf/cip1 in PHK cells after 11R-VIVIT treatment. n=5 for each sample group. * P,0.01,
{ P,0.05. (D) Effect of cyclin G2 overexpression on the proliferation of PHK cells. Cells were infected with recombinant adenoviruses carrying cyclin
G2 and lacZ at an MOI of 100. Overexpression of cyclin G2 significantly inhibited cell proliferation compared with LacZ-infected cells (*P,0.01). (E)
Expression of cyclin G2 in rat hair follicles at postnatal days 9 (first anagen stage) and 49 (second telogen stage). Arrowheads, differentiated
keratinocytes in a distal part of the hair shaft; arrows, proliferating keratinocytes in the proximal hair shaft. DP, dermal papillae; HG, hair germ; SG,
sebaceous gland. Scale Bar=50 mm.
doi:10.1371/journal.pone.0017685.g005
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In the present study, we cloned a novel splicing variant of CnAß
(CnAß–FK) in follicular keratinocytes. CnAß–FK lacked the
autoinhibitory domain, resulting in a constitutively active form,
and was localized in the nucleus of mature follicular keratinocytes
along with NFATc2. In contrast, CnAß–FK was not expressed in
immature keratinocytes of the hair germ. These results suggest that
constant activation of the CN/NFAT signaling pathway in mature
keratinocytes is involved in the regulation of hair growth. Normal
hair growth requires a balance between keratinocyte growth and
differentiation in the hair follicle [2]. CnAß–FK may be involved
in inhibition of follicular keratinocyte growth and the induction of
differentiation of the cells. One of the most common side effects of
treatment with the immunosuppressant drug CsA is hypertrichosis;
this condition affects 50–80% of transplant recipients treated with
the drug [28]. In hair follicle stem cells, inhibition of the Cn/
NFATc1 pathway by CsA induced the proliferation of stem cells
[5]. Overall, the results of previous studies and those described
here suggest that CsA inhibits both the CnAß–FK/NFATc2
pathway in follicular keratinocytes and the Cn/NFATc1 pathway
in follicular stem cells, resulting in excessive hair growth.
CnAß-FK is encoded by an intron-retaining mRNA and is
predominantly expressed in follicular keratinocytes. Under
ordinary intracellular conditions, intron-containing pre-mature
mRNAs are confined within the nucleus, or are degraded by the
cellular nonsense-mediated decay system when transported to the
cytoplasm; both of these mechanisms result in restriction of their
translation [29,30]. However, several recent studies have indicated
the existence of a mechanism for export of pre-mature mRNAs
from the nucleus [31,32], and also suggested that these mRNAs
may play physiologically important roles in addition to being
involved in pathological conditions [33–35]. Our results here
provide the first evidence that an intron-containing pre-mature
mRNA has a physiological function in the regulation of hair
follicle development. Although the mechanisms of pre-mRNA
nuclear export have been investigated, the details remain unclear
[36,37]. Further study is needed to determine the effects of intron
11 and 12 of CnAß on mRNA stability and on expression of
CnAß-FK. In the present study, we also found that CnAß-FK was
strongly expressed in cells of the sebaceous gland. There have been
no previous reports that Cn might have a function in the
sebaceous gland. It would be interesting to investigate the
physiological functions of CnAß-FK in the sebaceous gland.
Another extension of research on this variant would be to
investigate the mechanisms of alternative splicing and posttran-
scriptional modification.
Central dogma states that Cn activity in mammals is tightly
regulated by Ca
2+ through CnB and calmodulin binding. In
response to changes in intracellular Ca
2+ levels, the autoinhibitory
domain of CnA is removed and the catalytic site is exposed [38].
We showed previously that the autoinhibitory domain of CnA is
cleaved by calpain and that Cn becomes the constitutively active
form during neurodegeneration [15,23]. This pattern of cleavage
is also observed in patients with diseased myocardium [39],
suggesting that Cn changes the constitutively active form in some
pathological conditions. However, the present study demonstrated
that CnAß-FK was a normally occurring variant and was the
constitutively active form with a physiological function in mature
follicular keratinocytes. Moreover, a splicing variant form of CnAß
(variant 2 in Fig. 1C) has been cloned and is also encoded by an
intron-retaining mRNA [40]. In variant 2 of CnAß, the
autoinhibitory domain has been replaced with a unique C-
terminal region generated by the translation of intron 12 (41
amino acids); consequently, variant 2 is also constitutively active
[41]. A recent study showed that variant 2 is highly expressed in
proliferating myoblasts and regenerates skeletal muscle fibers [41].
Together, these findings indicate that constitutively active variants
of Cn may play important roles in the regulation of physiological
functions such as cell proliferation and differentiation in various
organs and tissues.
The present study showed that CsA blocked the Cn activity of
CnAß-FK. This result agrees with that of truncated CnA by
calpain [15,23]. In contrast, variant 2 of CnAß has reduced
sensitivity to the action of immmunosuppressants [41]. Variant 2
of CnAß has a unique C-terminal region generated by the
translation of intronic sequences. The alternative C-terminal
domain in variant 2 of CnAß may interfere with the binding of the
immunosuppressant- immunophilin complex to Cn and prevent its
inactivation. The side effects of immunosuppressants are seen in
hair follicles and SG as hypertrichosis and hyperplasia but not in
skeletal muscle. Differences in sensitivity to immunosuppressants
between CnAß-FK and variant 2 of CnAß might determine the
nature of any side effects of immunosuppressant treatment.
We showed here that cyclin G2 is a novel target of Cn/NFATc2
in follicular keratinocytes. Cyclin G2 is an atypical cyclin involved
in cell cycle arrest and apoptosis [19,27]. Previous studies
identified the cyclin-dependent kinase inhibitors p21
waf/cip1 and
p27
kip1 as targets of Cn/NFATc2 in follicular keratinocytes [4,16].
Both proteins inhibit proliferation and induce differentiation of
keratinocytes [4]. Overall, these observations suggest that
activation of the Cn/NFATc2 signaling pathway is involved in
the induction of the expression of some signaling molecules that
inhibit proliferation and induce terminal differentiation in
keratinocytes. Therefore, immunosuppressants may induce prolif-
eration of follicular keratinocytes and block terminal differentia-
tion in these cells.
In conclusion, the data we present here demonstrate a novel
signaling cascade involving CnAß-FK, a constitutively active
variant of CnA, that controls the growth of follicular keratinocytes
through the regulation of expression of cell-cycle regulatory genes
such as cyclin G2 and p21
waf/cip1.
Supporting Information
Figure S1 Full-length nucleotide sequence of human
CnAß-FK cDNA. (A) The underline indicates the ATG initiation
codon and the double underline indicates the stop codon. Black,
cDNA derived from exons; blue, cDNA derived from introns; red,
poly A tail. (B) Comparison of 39 sequence derived from exon 11
and 12 in CnAß variants. In CnAß-FK cDNA, two sequential stop
codons have been inserted at the 39 end of the cDNA derived from
exon 11 (arrow).
(TIF)
Figure S2 Comparison of the alignment of amino acid
sequences among each variant of CnAß. The thin bar
indicates the calmodulin-binding site and the thick bar indicates
the autoinhibitory domain (AID). Dashes indicate missing amino
acids. CnAß-FK and variant 2 have no autoinhibitory domain.
(TIF)
Figure S3 Localization of NFATc2 in PHK cells. Endog-
enous NFATc2 was observed in both cytoplasm and nucleus of the
cells. Scale Bar, 50 mm.
(TIF)
Figure S4 Expression of CnAß in male rat skin at
postnatal day 28. (A) Endogenous CnAß in hair follicle at a
Calcineurin Activation and Hair Development
PLoS ONE | www.plosone.org 10 March 2011 | Volume 6 | Issue 3 | e17685late phase of the anagen stage. (B and C) Higher magnification
views of the boxed regions in A. B, epidermal region; C, hair
follicle region. CnAß was observed in both epidermal and
follicular keratinocytes. Scale bar, 100 mm.
(TIF)
Figure S5 Distribution of CnAß-FK mRNA and NFATc2
in rat skin at postnatal days 24 and 25 (early phase of the
anagen stage). (A–D) Distribution of CnAß-FK mRNA. (A and
B), postnatal day 24 (P24); (C and D), postnatal day 25 (P25). (B
and D) Sections were counter-stained with hematoxylin (blue). (E
and F) Immunohistochemical analysis of NFATc2 in hair follicles
at P24 and P25. In HG cells, NFATc2 was present in the
cytoplasm. DP, dermal papillae; HG, hair germ; SG, sebaceous
gland. Scale bars, 50 mm.
(TIF)
Figure S6 Distribution of CnAß-FK mRNA in human
skin. CnAß-FK is also expressed in human hair follicle.
(TIF)
Figure S7 Effect of CnAß-FK overexpression on cyclin
G2 expression in Hela cells. HeLa cells were transfected with
the CnAß-FK/pcDNA3.1-V5-His vector. The cells were harvest-
ed 6, 12 and 24 h after the transfection and the amount of cyclin
G2 at each time point was measured by Western blotting. V5 is an
epitope tag fused with CnAß-FK.
(TIF)
Figure S8 Cyclosporin A reduces cyclin G2 expression
in hair follicles through NFATc2 inhibition. (A) Time-scale
of the hair cycle in male Wister rats. The intensity of gray shading
indicates the rate of proliferation of follicular keratinocytes as
described in Fig. 3a. (B–E) NFATc2 and cyclin G2 localization in
anagen stage hair follicles of a control rat. Arrows indicate nuclear
localization of NFATc2. Cyclin G2 was abundant in follicular
keratinocytes, similarly to that at P9 (Figure 5E). (F–I) NFATc2
and cyclin G2 in anagen stage hair follicles of a CsA-treated rat.
Note that cytoplasmic localization of NFATc2 was observed in
many cells (arrowheads in G), resulting in a decrease in cyclin G2
expression in follicular keratinocytes (I). Scale bars, 20 mm.
(TIF)
Table S1 Primer sequences for cloning of CnAß-FK. For
cloning the full nucleotide sequence of human CnAß-FK cDNA,
the PCR amplifications were performed according to the
sequential steps a, b, c (described in schema of CnAß-FK
mRNA). Details of the experimental procedure are given in the
‘‘Materials & Methods’’.
(TIF)
Table S2 Primer sequences for preparation of probes
for in situ hybridization. Anti-sense and sense probes were
prepared using a DNA template corresponding to the full
sequence of intron11; this sequence was produced using the
primers listed in Table S2. Further details of this procedure are
given in ‘‘Materials and Methods’’.
(TIF)
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